CMPK2
Basic information
Region (hg38): 2:6840570-6866635
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Basal ganglia calcification, idiopathic, 10, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 36443312 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CMPK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 52 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 52 | 5 | 0 |
Variants in CMPK2
This is a list of pathogenic ClinVar variants found in the CMPK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-6849890-G-A | not specified | Likely benign (May 24, 2024) | ||
2-6849954-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
2-6849959-T-C | BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 10, AUTOSOMAL RECESSIVE | Pathogenic (Nov 22, 2024) | ||
2-6849966-T-C | not specified | Likely benign (Oct 03, 2022) | ||
2-6851456-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
2-6851531-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
2-6851540-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
2-6851547-C-G | not specified | Uncertain significance (May 23, 2024) | ||
2-6851605-G-T | CMPK2-related disorder | Uncertain significance (Jan 10, 2023) | ||
2-6851655-T-C | not specified | Uncertain significance (Jun 30, 2024) | ||
2-6861199-G-A | not specified | Uncertain significance (May 26, 2024) | ||
2-6861226-T-G | not specified | Uncertain significance (Aug 04, 2023) | ||
2-6861326-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-6861370-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
2-6861376-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
2-6863466-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
2-6863482-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
2-6863484-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
2-6863503-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
2-6863553-C-T | not specified | Likely benign (Jan 16, 2024) | ||
2-6865038-C-A | not specified | Uncertain significance (Jul 09, 2024) | ||
2-6865051-G-A | not specified | Uncertain significance (Oct 30, 2024) | ||
2-6865052-G-C | not specified | Uncertain significance (Oct 09, 2024) | ||
2-6865053-T-C | not specified | Uncertain significance (Apr 15, 2024) | ||
2-6865056-G-A | not specified | Uncertain significance (Jul 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CMPK2 | protein_coding | protein_coding | ENST00000256722 | 5 | 26066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000113 | 0.362 | 124763 | 1 | 35 | 124799 | 0.000144 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.274 | 170 | 180 | 0.943 | 0.00000943 | 2788 |
Missense in Polyphen | 70 | 75.095 | 0.93215 | 986 | ||
Synonymous | 0.171 | 75 | 76.9 | 0.975 | 0.00000398 | 985 |
Loss of Function | 0.472 | 10 | 11.7 | 0.851 | 5.00e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000985 | 0.000984 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000389 | 0.000389 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000710 | 0.0000706 |
Middle Eastern | 0.000389 | 0.000389 |
South Asian | 0.000131 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May participate in dUTP and dCTP synthesis in mitochondria. Is able to phosphorylate dUMP, dCMP, CMP, UMP and monophosphates of the pyrimidine nucleoside analogs ddC, dFdC, araC, BVDU and FdUrd with ATP as phosphate donor. Efficacy is highest for dUMP followed by dCMP; CMP and UMP are poor substrates. May be involved in mtDNA depletion caused by long term treatment with ddC or other pyrimidine analogs. Also displays broad nucleoside diphosphate kinase activity. {ECO:0000269|PubMed:17999954, ECO:0000269|PubMed:23416111}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Pyrimidine Metabolism;UMP Synthase Deiciency (Orotic Aciduria);MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy);Beta Ureidopropionase Deficiency;Dihydropyrimidinase Deficiency;Pyrimidine metabolism;UTP and CTP <i>de novo</i> biosynthesis;superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis;superpathway of pyrimidine deoxyribonucleoside salvage;CMP phosphorylation;pyrimidine deoxyribonucleotide phosphorylation;superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.111
Haploinsufficiency Scores
- pHI
- 0.0719
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.575
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cmpk2
- Phenotype
- homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- nucleoside diphosphate phosphorylation;dUDP biosynthetic process;dTDP biosynthetic process;dTTP biosynthetic process;nucleoside triphosphate biosynthetic process;nucleoside monophosphate phosphorylation;cellular response to lipopolysaccharide
- Cellular component
- cytoplasm;mitochondrion
- Molecular function
- cytidylate kinase activity;nucleoside diphosphate kinase activity;thymidylate kinase activity;ATP binding;uridylate kinase activity;UMP kinase activity